ScoreWhy is SMS Pharmaceuticals Ltd ?
1
Poor long term growth as Operating profit has grown by an annual rate 16.91% of over the last 5 years
2
Positive results in Dec 25
- PAT(Latest six months) At Rs 48.78 cr has Grown at 50.83%
- NET SALES(Latest six months) At Rs 452.88 cr has Grown at 22.37%
- ROCE(HY) Highest at 12.36%
3
With ROCE of 13.1, it has a Expensive valuation with a 3.4 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 47.16%, its profits have risen by 35.5% ; the PEG ratio of the company is 1.5
4
Majority shareholders : Promoters
5
Consistent Returns over the last 3 years
- Along with generating 47.16% returns in the last 1 year, the stock has outperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to SMS Pharma. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is SMS Pharma. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
SMS Pharma.
47.16%
1.00
47.17%
Sensex
7.97%
0.69
11.53%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
15.42%
EBIT Growth (5y)
16.91%
EBIT to Interest (avg)
4.30
Debt to EBITDA (avg)
2.95
Net Debt to Equity (avg)
0.31
Sales to Capital Employed (avg)
0.80
Tax Ratio
26.23%
Dividend Payout Ratio
4.08%
Pledged Shares
17.99%
Institutional Holding
3.25%
ROCE (avg)
10.77%
ROE (avg)
9.74%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
32
Price to Book Value
4.11
EV to EBIT
24.08
EV to EBITDA
18.71
EV to Capital Employed
3.38
EV to Sales
3.59
PEG Ratio
1.49
Dividend Yield
0.12%
ROCE (Latest)
13.07%
ROE (Latest)
11.57%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend16What is working for the Company
PAT(Latest six months)
At Rs 48.78 cr has Grown at 50.83%
NET SALES(Latest six months)
At Rs 452.88 cr has Grown at 22.37%
ROCE(HY)
Highest at 12.36%
DEBT-EQUITY RATIO(HY)
Lowest at 0.45 times
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 99.68 cr
-2What is not working for the Company
INTEREST(9M)
At Rs 17.80 cr has Grown at 28.24%
Loading Valuation Snapshot...
Here's what is working for SMS Pharma.
Profit After Tax (PAT) - Latest six months
At Rs 48.78 cr has Grown at 50.83%
Year on Year (YoY)MOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Net Sales - Latest six months
At Rs 452.88 cr has Grown at 22.37%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.45 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Cash and Cash Equivalents - Half Yearly
Highest at Rs 99.68 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Here's what is not working for SMS Pharma.
Interest - Nine Monthly
At Rs 17.80 cr has Grown at 28.24%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Non Operating Income - Quarterly
Highest at Rs 3.75 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
